Search clinical trials for: BN83495

Total 7 results

Ipsen

Completed

BN83495 in Prostate Cancer (STX64PC)

Prostate Cancer

United States
Ipsen

Terminated

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Endometrial Cancer

United States, Canada
Ipsen

Terminated

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Breast Cancer

Norway
Ipsen

Completed

BN83495 Phase I in Post-menopausal Women

Breast Cancer

France, United Kingdom, Belgium
Imperial College London
University of Southern California; Guy's and St Thomas' NHS Foundation Trust; Ipse... and other collaborators

Terminated

A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth (IPET)

Breast Neoplasms

United Kingdom
Imperial College London
Cancer Research UK

Completed

A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. (IRIS)

Metastatic Breast Cancer | Locally Advanced Breast Cancer

United Kingdom
Ipsen

Completed

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Endometrial Cancer

Czechia, France, United Kingdom, Belgium, Latvia, Hungary, Lithuania, Moldova, Republic of, Poland, Russian Federation, Spain, Ukraine

3

Subscribe